Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank93
3Y CAGR+14.4%
5Y CAGR+10.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+14.4%/yr
vs -1.3%/yr prior
5Y CAGR
+10.0%/yr
Recent acceleration
Acceleration
+15.7pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
6 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$18.37M+4.3%
2024$17.61M+25.0%
2023$14.09M+14.8%
2022$12.28M+1.7%
2021$12.07M+5.9%
2020$11.40M+370.2%
2019$2.42M-81.3%
2018$12.93M+8.2%
2017$11.95M-30.3%
2016$17.14M-